Lancy Saldanha

Lancy Saldanha serves as Chief Executive Officer at Despina Pharma Inc. Despina Pharma Inc operates in the pharmaceuticals sector with approximately 24.0 employees. The company is headquartered in Metro Manila.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 196 executive contacts are available in Metro Manila.
• • Our database includes 201,465 c suite-level executives.

Google Font API WordPress.org Apache Mobile Friendly

oral injectables vaccines nutritional supplements generic medicines tropical formulations parenteral formulations pharmaceutical manufacturing nutraceuticals healthcare critical care patient-centered community care primary care integrated healthcare medical needs therapeutic segments oncology cardiology diabetology nephrology neurology anti-infective anti-allergy market research drug development clinical research homecare long-term care hospital care market development quality management supply chain healthcare solutions medication affordability patient care health improvement innovation research & development regulatory compliance community initiatives brand building healthcare partnerships sustainability customer satisfaction transparency patient trust ethical standards logistics pharma industry clinical affairs healthcare marketing health education social responsibility health services pharmaceuticals medical health care health wellness & fitness hospital & health care long term care environmental services renewables & environment

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Lancy Saldanha in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Despina Pharma Inc.

Lancy Saldanha's Position in the MessageCEO Database

• •Lancy Saldanha is 1 of 1 verified executive contact we track at Despina Pharma Inc.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •195 verified executive contacts in Metro Manila are in the database.
• •10 verified contacts work at pharmaceuticals companies in the 24.0 employee range (same size as Despina Pharma Inc).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated October 2026.

How do I reach Lancy Saldanha directly?

Lancy Saldanha's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Despina Pharma Inc. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Lancy Saldanha work for?

Lancy Saldanha is Chief Executive Officer at Despina Pharma Inc, a company in the pharmaceuticals sector with 24.0 employees. The company is based in Metro Manila.

Can I pitch or sell to Lancy Saldanha?

As Chief Executive Officer at Despina Pharma Inc, Lancy Saldanha is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Lancy Saldanha directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Lancy Saldanha in?

Lancy Saldanha works in the pharmaceuticals industry as Chief Executive Officer at Despina Pharma Inc. MessageCEO provides verified contact information for executives across all major industries.

Is Lancy Saldanha's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Lancy Saldanha's profile is kept up-to-date with the latest available information.

Last updated: October 26, 2026